Associated Banc Corp Ultragenyx Pharmaceutical Inc. Transaction History
Associated Banc Corp
- $3.64 Billion
- Q3 2025
Shares
2 transactions
Others Institutions Holding RARE
# of Institutions
362Shares Held
91.1MCall Options Held
3.65MPut Options Held
2.26M-
Vanguard Group Inc Valley Forge, PA10.1MShares$324 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$179 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY4.01MShares$128 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.94MShares$126 Million0.43% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.89MShares$92.2 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.24B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...